These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37627093)

  • 81. Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors.
    Wolin EM; Manon A; Chassaing C; Lewis A; Bertocchi L; Richard J; Phan AT
    J Gastrointest Cancer; 2016 Dec; 47(4):366-374. PubMed ID: 27619395
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease.
    Alexander ES; Ziv E
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190177
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review.
    Regolo M; Cardaci N; Salmeri C; Laudani A; Colaci M; Ippolito M; Motta F; Magrì S; Parisi S; Torcitto AG; Malatino L
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892755
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Carcinoid Heart Disease: How to Diagnose and Treat in 2020?
    Bober B; Saracyn M; Kołodziej M; Kowalski Ł; Deptuła-Krawczyk E; Kapusta W; Kamiński G; Mozenska O; Bil J
    Clin Med Insights Cardiol; 2020; 14():1179546820968101. PubMed ID: 33192110
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multiple Small Intestinal Neuroendocrine Tumors With Findings of Intestinal Obstruction.
    Basendowah MH; Ashour MA; Hassan AY; Alshaynawi S; Alyazidi LK
    Cureus; 2021 Sep; 13(9):e17629. PubMed ID: 34646678
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Neuroendocrine tumours of the small intestine.
    Strosberg J
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):755-73. PubMed ID: 23582917
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Current Perspective on the Pathogenesis of Small Intestinal Neuroendocrine Tumors: Progress in Biomarkers and Molecular Events.
    Chen YX; Fang JY
    Gastrointest Tumors; 2013 Sep; 1(1):2-8. PubMed ID: 26674261
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
    Nölting S; Kuttner A; Lauseker M; Vogeser M; Haug A; Herrmann KA; Hoffmann JN; Spitzweg C; Göke B; Auernhammer CJ
    Cancers (Basel); 2012 Feb; 4(1):141-55. PubMed ID: 24213232
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.
    Drozdov I; Kidd M; Nadler B; Camp RL; Mane SM; Hauso O; Gustafsson BI; Modlin IM
    Cancer; 2009 Apr; 115(8):1638-50. PubMed ID: 19197975
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors.
    Nonaka D; Papaxoinis G; Mansoor W
    Am J Surg Pathol; 2016 Jun; 40(6):738-44. PubMed ID: 26927888
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
    Dobson R; Burgess MI; Banks M; Pritchard DM; Vora J; Valle JW; Wong C; Chadwick C; George K; Keevil B; Adaway J; Ardill JE; Anthoney A; Hofmann U; Poston GJ; Cuthbertson DJ
    PLoS One; 2013; 8(9):e73679. PubMed ID: 24069222
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical and biochemical aspects of the carcinoid syndrome in neuroendocrine tumors of the abdominal and retroperitoneal organs and its impact for the disease prognosis.
    Polikarpova SB; Lubimova NV; Ogereliev AS; Britvin TA; Davidov MI
    Bull Exp Biol Med; 2009 Nov; 148(5):803-6. PubMed ID: 20396797
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Update in carcinoid heart disease - the heart of the matter.
    Oleinikov K; Korach A; Planer D; Gilon D; Grozinsky-Glasberg S
    Rev Endocr Metab Disord; 2021 Sep; 22(3):553-561. PubMed ID: 33443717
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
    Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
    Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Normalization of Prediabetic Hemoglobin A1c (HbA1c) Levels After the Surgical Removal of a Serotonin-Secreting Neuroendocrine Tumor.
    Tskitishvili A; Lobjanidze M; Turmanishvili Z; Mamulashvili N; Bejanishvili T
    Cureus; 2024 Apr; 16(4):e57376. PubMed ID: 38694675
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Screening for carcinoid heart disease: Trends and future Perspectives.
    Mouser B; Howe JR; Atari O; Dillon JS; Chandrasekharan C; Parekh KR; Bashir MA
    Int J Cardiol Cardiovasc Risk Prev; 2024 Sep; 22():200293. PubMed ID: 38911359
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art.
    Rossi RE; Lavezzi E; Jaafar S; Cristofolini G; Laffi A; Nappo G; Carrara S; Bertuzzi AF; Uccella S; Repici A; Zerbi A; Lania AGA
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627093
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
    de Mestier L; Savagner F; Brixi H; Do Cao C; Dominguez-Tinajero S; Roquin G; Goichot B; Hentic O; Dubreuil O; Hautefeuille V; Walter T; Cadiot G
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1673-e1682. PubMed ID: 33382891
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
    Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
    Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.